MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-UP-15-0005230
Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals Private Limited - trading in Bareilly, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.67 Lakh
▲ 32% YoY
Net profit · FY 2025
₹41,427
Net margin 1%
EBITDA · FY 2025
₹55,983
EBITDA margin 1.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Earl Pharmaceuticals Private Limited
Data last updated:
Earl Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 01 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24299UP2016PTC085305. Its GSTIN is 09AAECE4101B1ZC (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It was formerly known as Sunup Pharmaceuticals Private Limited and Aurora Pharmaceuticals Private Limited. It is led by directors Bhawana Srivastava and Sandeep Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 91 Officers Enclave Karam Chari Nagar, Bareilly, Uttar Pradesh, India – 243001.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.67 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹41,427 (net margin 1%) and EBITDA of ₹55,983 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Earl Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-15-0005230). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24299UP2016PTC085305
Registration Number 085305
Incorporation Date 01 August 2016
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-15-0005230
Name history
Earl Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Sunup Pharmaceuticals Private Limited, Aurora Pharmaceuticals Private Limited, and Benison Pharmaceuticals Private Limited. The current legal name is Earl Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Earl Pharmaceuticals Private Limited | Current |
| Sunup Pharmaceuticals Private Limited | Previous |
| Aurora Pharmaceuticals Private Limited | Previous |
| Benison Pharmaceuticals Private Limited | Previous |
Recognitions & Rankings of Earl Pharmaceuticals
Contact details
Earl Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address91 Officers Enclave Karam Chari Nagar, Bareilly, Uttar Pradesh, India – 243001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Earl Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Earl Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Earl Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Earl Pharmaceuticals Private Limited, buy the company report.
Financials of Earl Pharmaceuticals Private Limited
FY 2025 filings availableEarl Pharmaceuticals Private Limited reported revenue of ₹39.67 Lakh (up 32% YoY) for FY 2025.
Revenue · FY 2025
₹39.67 Lakh ▲ 32%
Net profit · FY 2025
₹41,427 margin 1%
EBITDA · FY 2025
₹55,983 margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 20%
5 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 34% over three years, including 32% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55,983 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41,427 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Earl Pharmaceuticals Private Limited, buy the company report.
Board of directors of Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhawana Srivastava | Director | 20 Feb 2024 | 2 Years 8 Months | Current |
| Sandeep Kumar Srivastava | Director | 12 Aug 2022 | 4 Years 2 Months | Current |
Peer comparison
Earl Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axonwave Pharmaceuticals Private Limited | ₹39.76 Lakh (FY 2025) | -7.0% | Uttamnagar, Delhi, India | |||
| Earl Pharmaceuticals Private Limitedthis company | ₹39.67 Lakh (FY 2025) | ₹41,427 | 1% | 32.0% | Bareilly, Uttar Pradesh, India | |
| Pharmella Pharmaceuticals Private Limited | ₹39.64 Lakh (FY 2025) | 13.0% | Eluru, Andhra Pradesh, India | |||
| Asap Pharmaceuticals Private Limited | ₹39.48 Lakh (FY 2025) | 5.0% | Patna, Bihar, India |
To see the full peer comparison of Earl Pharmaceuticals Private Limited, buy the company report.
Auditor
Earl Pharmaceuticals Private Limited is audited by RAJAN SHUKLA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJAN SHUKLA & CO. | FY 2017 | 016737C |
Shareholding
The shareholding of Earl Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Earl Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2023 | 100685362 | State Bank of India | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Earl Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Earl Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Earl Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECE4101B1ZC | Uttar Pradesh | Active | 16 Mar 2021 |
To see the full GST registrations and return filing status of Earl Pharmaceuticals Private Limited, buy the company report.
Recent activity
Earl Pharmaceuticals Private Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Ayushi Srivastava ceased to be Director on 20 Feb 2024.
AGM
Earl Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Earl Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Ayushi Srivastava ceased to be Director.
Appointed
Bhawana Srivastava was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 15.00 Lakh with Charge ID 100685362 was registered on 27 Feb 2023.
Appointed
Sandeep Kumar Srivastava was appointed as Director.
Ceased
Anjuli Srivastava ceased to be Director.
Appointed
Ayushi Srivastava was appointed as Director.
Appointed
Anjuli Srivastava was appointed as Director.
Incorporation
01 Aug 2016
Earl Pharmaceuticals Private Limited was registered on 01 Aug 2016 with Roc Kanpur & aged 10 years 2 months as per MCA records.
Frequently asked questions
Earl Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 01 August 2016 (10+ years old) and is registered under CIN U24299UP2016PTC085305.
Earl Pharmaceuticals has 2 current directors:
- Bhawana Srivastava - Director
- Sandeep Kumar Srivastava - Director
The latest financial statements of Earl Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Earl Pharmaceuticals is 09AAECE4101B1ZC, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Earl Pharmaceuticals is U24299UP2016PTC085305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Earl Pharmaceuticals was incorporated on 01 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Earl Pharmaceuticals by revenue are Axonwave Pharmaceuticals Private Limited, Pharmella Pharmaceuticals Private Limited, Asap Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ayushi Srivastava ceased to be Director on 20 Feb 2024. Bhawana Srivastava was appointed as Director on 20 Feb 2024. Sandeep Kumar Srivastava was appointed as Director on 12 Aug 2022. Earl Pharmaceuticals has 6 board changes on record in total.
Yes, Earl Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-15-0005230).
The registered office of Earl Pharmaceuticals is at 91 Officers Enclave Karam Chari Nagar, Bareilly, Uttar Pradesh, India – 243001.
Earl Pharmaceuticals operates in the trading industry, in the other wholesale segment.